Goldiam International Q1 FY27 Earnings Call Transcript Released
Goldiam International reported Q1 FY27 revenue of ₹3,637 million and EBITDA of ₹1,039 million, a 120% increase. Profit after tax doubled to ₹740 million. Lab-grown diamond jewelry exports were 90.7% of export sales. The company allotted bonus shares (1:3 ratio) in July and has 26 ORIGEM stores contributing ₹81.56 million in Q1 FY27.
The release of an earnings call transcript provides detailed insights into the company's financial performance and strategic outlook. The strong financial results and growth in key segments like lab-grown diamonds are material information for investors.
The company reported strong financial results with significant growth in revenue, EBITDA, and profit after tax. The expansion of lab-grown diamond jewelry exports and the positive performance of the ORIGEM brand also contribute to a positive sentiment.
Goldiam International Limited has released the transcript of its Earnings Conference Call for the quarter ended June 30, 2026, which was held on August 10, 2026. The call, hosted by Monarch Networth Capital Limited, featured Executive Chairman Mr. Rashesh Bhansali and Director Mr. Anmol Bhansali. The company reported strong growth momentum in Q1 FY27, with total revenue of ₹3,637 million. EBITDA for the quarter grew by 120% to ₹1,039 million, and the EBITDA margin increased by 400 basis points to 24%. Profit after tax more than doubled to ₹740 million. Lab-grown diamond jewelry exports constituted 90.7% of the export sales mix. Online revenue accounted for 19.3% of total revenue. The company's order book stood at ₹2,250 million as of June 30, 2026. Cash and cash equivalents, including investments, were ₹4,566.7 million. In July, Goldiam allotted 3,76,39,281 bonus equity shares in a 1:3 ratio.
The company's India-focused B2B lab-grown diamond jewelry retail brand, ORIGEM, has 26 operational stores and recorded ₹81.56 million in revenue for Q1 FY27. The management discussed the strong performance in the B2B segment, driven by increased demand for lab-grown diamonds in the U.S. and expansion into new geographies like the Middle East and Israel. They highlighted the successful launch of bracelet and necklace categories in the U.S. and the positive reception.
Discussions also covered margin expansion strategies, including a dual casting method and the impact of other income, which included tariff refunds, forex gains, and treasury gains. The company reiterated its commitment to margin improvement. Regarding ORIGEM, plans are in place to open approximately 7 more stores by pre-Diwali, with a focus on increasing sales per store. The company also elaborated on its competitive advantages in the lab-grown diamond jewelry space, citing design strength, manufacturing expertise, and strong retail partnerships. Future growth is expected from both the B2B and B2C segments, with a focus on increasing penetration in the U.S. market and expanding the ORIGEM retail footprint.
What to do with a filing like this
Goldiam International Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Goldiam International Limited. Read the original for the full detail.